Crossmark

Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial

Crossref DOI link: https://doi.org/10.1007/s10157-015-1106-2

Published Online: 2015-03-21

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kato, Sawako

Maruyama, Shoichi

Makino, Hirofumi

Wada, Jun

Ogawa, Daisuke

Uzu, Takashi

Araki, Hisazumi

Koya, Daisuke

Kanasaki, Keizo

Oiso, Yutaka

Goto, Motomitsu

Nishiyama, Akira

Kobori, Hiroyuki

Imai, Enyu

Ando, Masahiko

Matsuo, Seiichi
License Information

Text and Data Mining valid from 2015-03-21